Tenet Healthcare (THC) Capital Expenditures (2012 - 2026)

Tenet Healthcare (THC) has 15 years of Capital Expenditures data on file, last reported at $180.0 million in Q1 2026.

• Quarterly Capital Expenditures rose 4.05% year-over-year to $180.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 17.71% YoY) and the FY2025 annual result came in at $1.0 billion, up 8.49% from the prior year.
• Capital Expenditures slipped to $180.0 million in Q1 2026 per THC's latest filing, from $364.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $364.0 million in Q4 2025, with the low at $132.0 million in Q2 2023.
• Average Capital Expenditures over 5 years is $213.8 million, with a median of $193.0 million recorded in 2025.
• Year-over-year, Capital Expenditures slipped 28.28% in 2023 and soared 58.65% in 2024.
• Tenet Healthcare's Capital Expenditures stood at $290.0 million in 2022, then fell by 28.28% to $208.0 million in 2023, then jumped by 58.65% to $330.0 million in 2024, then climbed by 10.3% to $364.0 million in 2025, then plunged by 50.55% to $180.0 million in 2026.
• Business Quant data shows THC's Capital Expenditures at $180.0 million in Q1 2026, $364.0 million in Q4 2025, and $280.0 million in Q3 2025.